SSSüleyman Sönmez

Süleyman Sönmez

*This is an algorithmically generated author record based on publicly available information.

Süleyman Sönmez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of the cystocholedochal angle in patients with choledocholithiasis and only cholelithiasis

    by Zekiye Karaca Bozdağ, Emre Bozdağ, Suleyman Sonmez, Ayça Pamukcu Beyhan, Alper Atasever

    This study aims to evaluate the relation between the cystocholedochal angle (SCA) and choledocholithiasis. The data of 3.350 patients were reviewed retrospectively and a total of 628 patients who met the criteria were included in the study. The patients included in the study were divided into three groups as patients with choledocholithiasis (Group I), patients with only cholelithiasis (Group II), and patients without gallstones as control group (Group III). Measurements of SCA, cystic, bile, and common hepatic ducts (CHDs) were made on magnetic resonance cholangiopancreatography (MRCP) images. Laboratory findings and demographic characteristics of the patients were also recorded. Of the patients included in the study 64.2% were female, 35.8% were male, and their age ranged from 18 to 93 (mean 53.37 ± 18.87 years). While the mean SCA values of all patient groups were 35.44° ± 10.44°, the mean length of cystic, bile and CHDs were 28.91 ± 9.30, 40.28 ± 12.91, 27.09 ± 9.68 mm respectively. All measurements were higher in Group I in comparison to other groups, whereas all measurements of Group II were higher than those of Group III (p < 0.001). Statistical analysis suggests that a SCA of 33.5° and above is an important criterion for diagnosis of choledocholithiasis. Increase of SCA raises the likelihood of choledocholithiasis, as it facilitates the passage of stones from gallbladder into the bile ducts. This is the first study to compare SCA in patients with choledocholithiasis and those with only cholelithiasis. Therefore, we think that this study is important and will be a guide for clinical evaluation.


  • Open Access

    Meme Hastalıkları

    by Zekiye Karaca Bozdağ, Buse Naz Çandır, Tuğçe Bölme Şavlı, Süleyman Sönmez, Aziz Ocakoğlu, Hakan Bölükbaşı, Fadime Didem Trabulus, Hüsnü Şevik, Yahya Kemal Çalışkan, Oğuzhan Tekin, et al.

    Memenin Embriyolojisi ve Anatomisi Zekiye KARACA BOZDAĞ Buse Naz ÇANDIR Meme Hastalıklarında Patoloji Tuğçe BÖLME ŞAVLI Meme Radyolojisi Süleyman SÖNMEZ Mastodini Aziz OCAKOĞLU Hakan BÖLÜKBAŞI Selim Meme Hastalıkları Fadime Didem TRABULUS Hüsnü ŞEVİK Meme Kanserinde Korunma ve Tarama Stratejileri Yahya Kemal ÇALIŞKAN Meme Kanserinin Klinik Özellikleri, Tanı ve Evreleme Oğuzhan TEKİN Meme Kanserinde Sistemik Tedavi Yaklaşımları Sevinç DAĞIŞTANLI Meme Kanseri Tedavisinde Radyoterapi Yusuf BİLGİN Meme Kanserinin Cerrahi Tedavisi Berrin ÖNALAN Onkoplastik Meme Cerrahisi Tansu ALTINTAŞ Meme Kanserinde İzlem İsmail Hakkı Alp SOLAK

  • The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results

    by Mehmet Kolu, Osman Dere, Süleyman Sönmez

    Background and Aims: This study aimed to investigate the tumor response and effect of treatment on survival in patients diagnosed with hepatocellular carcinoma (HCC) undergoing drug-eluting transarterial chemoembolization (DEB-TACE). Materials and Methods: 40 patients who underwent DEB-TACE between March 2018 and November 2020 were retrospectively analyzed. The patients were followed up with abdominal computed tomography, serum albumin, bilirubin, prothrombin time, and α-fetoprotein values. European Association for Study of the Liver criteria were used to evaluate the treatment response. Results: A total of 70 TACE sessions were performed in 40 patients with HCC. The etiology of the patients was chronic hepatitis B vırus (n=32), secondary biliary cirrhosis (n=2), cryptogenic (n=2), chronic hepatitis C vırus (n=4). Based on TACE response, complete response was observed in 22 patients, partial response in 8 patients, and progression in 10 patients. Liver transplantation was performed in 4 patients who developed complete response. In addition, the formation of new nodules was observed in 8 patients during the follow-up period, whereas 29 patients survived and 11 died. Conclusion: In this study, it was found that DEB-TACE had a positive effect on the survival of patients diagnosed with HCC who could not be surgically treated.